We have observed that the expression of p-p38/P-38, P-ERK1/2/ERK1/2, p-JNK/JNK, and p-NF-κB p65/ NF-κB p65 were notably inhibited following HE treatment. The gene discussed is MAPK3; the disease is hereditary elliptocytosis.